作者: Gianni Bonadonna , Armando Santoro
DOI: 10.1016/S0065-230X(08)60427-3
关键词:
摘要: Publisher Summary Hodgkin's disease represents a remarkable example in the history of clinical oncology how progress and laboratory research has been successfully translated into effective management programs. The treatment strategy applied to evolved through important concepts technical events. This chapter discusses major steps leading present achievements that can be useful outline potential new advances aimed at total conquest this disease. fact no stage is beyond cure after initial program present, even recurrence following primary irradiation, dramatic improvement overall prognosis Furthermore, considering rate radiation therapy most consistent finding survival benefit for combined modality patients with PS IIIA, studies should evaluate utilizing non-cross-resistant combinations. Treatment start chemotherapy alternated irradiation.